ReviewFrontiers in oncology2023

Research Topic: Measurable Residual Disease in Hematologic Malignancies. Can digital droplet PCR improve measurable residual disease monitoring in chronic lymphoid malignancies?

Giovanni Manfredi Assanto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.